(Q42980344)

12 November 2017

title

The role of ribavirin-induced mutagenesis in HCV therapy: a concept or a fact? (English)

1 reference

12 November 2017

The role of ribavirin-induced mutagenesis in HCV therapy: A concept or a fact? (English)

1 reference

https://api.crossref.org/works/10.1053/JHEP.2003.50464

15 March 2024

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512867

15 March 2024

author name string

Zhi Hong

series ordinal

1

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

12 November 2017

1 reference

12 November 2017

volume

38

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

807-810

1 reference

The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

RNA virus error catastrophe: direct molecular test by using ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

Ribavirin causes error catastrophe during Hantaan virus replication.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

The origin of genetic information: viruses as models

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

Prolonged therapy of chronic hepatitis C with ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

Reduction of synonymous substitutions in the core protein gene of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

Antiviral actions of interferons

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

Basic concepts in RNA virus evolution

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380406

7 January 2021

The New England Journal of Medicine

4

339

1485

McHutchison

1998

1 reference

https://api.crossref.org/works/10.1053/JHEP.2003.50464

15 March 2024

6

6

1375

Crotty

2000

1 reference

https://api.crossref.org/works/10.1053/JHEP.2003.50464

Proceedings of the National Academy of Sciences of the United States of America

15 March 2024

8

98

6895

Crotty

2001

1 reference

https://api.crossref.org/works/10.1053/JHEP.2003.50464

Proceedings of the National Academy of Sciences of the United States of America

15 March 2024

9

100

7289

Pfeiffer

2003

1 reference

https://api.crossref.org/works/10.1053/JHEP.2003.50464

15 March 2024

Identifiers

10.1002/HEP.1840380406

1 reference

12 November 2017

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14512867

15 March 2024

1 reference